Tissue and Hygiene in Guatemala

Overview

Discover the latest market trends and uncover sources of future market growth for the Tissue and Hygiene industry in Guatemala with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Tissue and Hygiene industry in Guatemala, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Guatemala for free:

• Away-from-home tissue and hygiene
• Cotton wool, buds, and pads
• Incontinence
• Kitchen towels
• Nappies, diapers, and pants
• Paper tableware
• Sanitary protection
• Tissues
• Toilet paper
• Wipes

The Tissue and Hygiene in Guatemala market research report includes:

• Analysis of key supply-side and demand trends
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

• What is the market size of Tissue and Hygiene in Guatemala?
• What are the major brands in Guatemala?
• What are the most dynamic tissue and hygiene categories?
• What are the major markets for tissue products sales?
• What are the major markets for hygiene products sales?

Why buy this report?

• Gain competitive intelligence about market leaders
• Track key industry trends, opportunities and threats
• Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Tissue and Hygiene market research database.

Sample Analysis

EXECUTIVE SUMMARY

Healthy value growth is recorded in tissue and hygiene during 2011
2011 was a good year for tissue and hygiene in Guatemala. Value sales increased in all categories as many of the products categorised under tissue and hygiene in Guatemala are used on a daily basis. Guatemala’s urban areas account for by far the majority of tissue and hygiene users as the higher disposable incomes of Guatemala’s urban dwellers means that they purchase more tissue and hygiene products and tend to opt for higher quality products when doing so.

Retail tissue and hygiene is a very dynamic category in Guatemala
The entrance of more efficient tissue and hygiene products with value added properties and strong advertising campaigns undertaken by the country’s leading tissue and hygiene companies has led to tissue and hygiene in Guatemala becoming a dynamic industry. As the consumer base for tissue and hygiene continues to widen due to increasingly rapid urbanisation and rising disposable incomes as more women join Guatemala’s workforce, the companies which are present in tissue and hygiene in Guatemala continue to innovate and introduce products offering benefits which will attract higher numbers of consumers.

International companies continue to lead tissue and hygiene
The presence of international companies remains strong in tissue and hygiene in Guatemala. Many international brands have a longstanding presence in the country, which allows them stronger brand recognition and higher levels of consumer loyalty. These international companies tend to engage in the most interesting advertising campaigns and a high degree of new product development, allowing them access to more consumer attention. Domestic brands are also present in tissue and hygiene in Guatemala, but these brands usually compete by offering basic low-quality products to price-sensitive low income consumers.

Stronger distribution chains needed in tissue and hygiene in Guatemala
Guatemala is a small country, but one with a high percentage of the population living in rural areas. These rural consumers usually have low disposable incomes and the presence of tiendas de barrio—community-centred retail outlets categorised under independent small grocers—is very important. Independent small grocers accounted for 44% of total tissue and hygiene retail value sales in 2011. The companies distributing their tissue and hygiene products through this channel need to have strong distribution chains in order to reach the many outlets in remote locations. Even though there are more supermarkets being opened in rural areas of Guatemala, they are not yet present in small towns, where independent small grocers continue to dominate the retailing landscape.

Stronger growth expected in tissue and hygiene during the forecast period
It is expected that tissue and hygiene in Guatemala will register stronger volume growth terms during the forecast period than the volume growth which was recorded during the review period. The main driver of volume growth over the forecast period is set to be the wider consumer base for tissue and hygiene due to population growth and rising disposable income levels. The companies which operate in tissue and hygiene in Guatemala face a massive challenge during the forecast period: to increase use of tissue and hygiene among Guatemalans as the per capita use of products such as nappies/diapers and incontinence products is among the lowest in Latin America. The introduction of smaller pack sizes is playing a positive role in increasing consumption of tissue and hygiene as these smaller products carry lower retail selling prices and are therefore seen as more affordable for Guatemalan consumers.

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181615-tissue-and-hygiene-in-guatemala.html

Report Details:
Published: July 2012
Price: Single User License- US $2400             
                                  

Case Study: Personalized Cancer Therapy - Anticipated competition threatens to dampen commercial potential of new approvals

The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the pharmaceutical industry to search for disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy.

Features and benefits

• In-depth analysis of companion diagnostic development – when to start development, internal or partnership development, with case study examples
• In-depth analysis of personalized cancer therapy commercial potential – with patient population analysis and case studies
• In-depth analysis of US, EU, and Japanese current and developing regulatory processes for personalized cancer therapy
• Extensive analysis of Zelboraf and Xalkori, including seven major market sales forecasts 2011-21 and detailed development timelines

Highlights
Pharmaceutical companies face a number of important decisions regarding personalized therapy development. Selecting the correct time to begin companion diagnostic development will help improve the chances of approval and drive new drug uptake. Developers must also assess their position in the market before choosing internal or external development.

The development of BRAF inhibitor resistance and anticipated launch of GlaxoSmithKline’s two personalized therapies will undoubtedly impact Zelboraf’s commercial potential. The question remains as to whether a small subgroup of patients in one indication can commercially support two almost identical drugs.

Regulators have now realized that the regulatory framework must be altered to incorporate both drugs and companion diagnostics. The US, EU and Japanese authorities are all starting to change their guidelines to encourage personalized therapy development. However, there are still hurdles to overcome before co-development becomes common practice.

Your key questions answered

• Gain extensive insight into the clinical and commercial aspects of Zelboraf and Xalkori, including 2011-21 forecasts
• Identify key decisions when developing a drug and companion diagnostic, including internal or external development and when to start development
• Assess the changes in regulatory processes in the seven major markets as the paradigm of personalized cancer medicine grows

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181601-case-study-personalized-cancer-therapy-anticipated-competition-threatens-to-dampen-commercial-potential-of-new-approvals.html


Report Details:
Published: July 2012
No. of Pages: 71
Price: Single User License- US $1900                Corporate User License- US $ 4750
                                  

Table Of contents

OVERVIEW
Catalyst
Summary

EXECUTIVE SUMMARY
Strategic scoping and focus
Datamonitor key findings
Related reports

INTRODUCTION
Oncology overview
A move toward personalized therapy with the development of targeted drugs

BIOMARKERS
Oncology biomarkers
Definition
Classification of cancer biomarkers
Targeted therapies and predictive biomarkers

DRUG AND COMPANION DIAGNOSTIC DEVELOPMENT
Case study
Iressa (gefitinib; AstraZeneca)
Development approach
Overview
When to develop companion diagnostics
Internal or external companion diagnostic development

COMMERCIAL POTENTIAL
Patient population
(Untitled sub-section)
Herceptin (trastuzumab; Roche/Genentech/Chugai)
Erbitux (cetuximab; Bristol-Myers Squibb/Eli Lilly/Merck KGaA) and Vectibix (panitumumab; Amgen)
Cost-effectiveness
Companion diagnostics make cancer treatments more cost-effective
Reimbursement
Reimbursement policies must consider personalized cancer therapy

REGULATORS
Regulators and personalized cancer therapy
Regulations are changing to encourage companion diagnostic co-development
US regulatory authorities
EU regulatory authorities
Japanese regulatory authorities

KEY MARKETED PERSONALIZED CANCER THERAPIES
Zelboraf (vemurafenib; Roche/Daiichi Sankyo)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Development path
Commercial potential
Clinical and commercial assessment
Xalkori (crizotinib; Pfizer)
Drug profile
Drug overview
Companion diagnostic overview
Development path
Commercial potential
Clinical and commercial potential

KEY PIPELINE PERSONALIZED CANCER TERAPIES
Dabrafenib (GSK-2118436; GlaxoSmithKline)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Market potential
Trametinib (GSK-1120212; GlaxoSmithKline)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Market potential
Tomtovok (afatinib; Boehringer Ingelheim)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Market potential
Other pipeline personalized cancer therapies
Overview of other pipeline personalized cancer therapies

BIBLIOGRAPHY
Journals
Websites
Datamonitor reports
Other

APPENDIX
Forecast methodology
Volume and value forecast methodology
Price assumptions
Contributing experts
Report methodology

List Of Tables
Table: Biomarker classification according to modality
Table: Examples of available companion diagnostics for targeted cancer therapies, 2012
Table: Approved cancer drugs with biomarkers on label, 2012
Table: Iressa: key historical events, 1994–2010
Table: Pharmaceutical company acquisitions of diagnostic companies, 2012
Table: Examples of diagnostic and pharmaceutical company partnerships for cancer therapies, 2010–12
Table: FDA-approved HER2 diagnostic tests, 2012
Table: FDA- and EMA-approved drugs with mandatory biomarker tests, 2012
Table: Zelboraf – drug profile, 2012
Table: Zelboraf sales forecast, by country ($m), 2011–21
Table: Xalkori – drug profile, 2012
Table: Xalkori sales forecast, by country ($m), 2011–21
Table: Dabrafenib – drug profile, 2012
Table: Trametinib – drug profile, 2012
Table: Tomtovok – drug profile, 2012
Table: Key pipeline personalized cancer therapies


Contact sales@reportsandreports.com for further details.

Software Testing for CSPs - Market Analysis

This 60-page report presents the results of our extensive primary research into the demand and supply of independent software testing services within communications service providers (CSPs) around the world.

Our analysis gives never before published market information including trends, drivers, market sizing and competitive analysis in the software testing segment based on direct customer and supplier interviews.

The main subjects covered by this report include:

• Analysis of the current communications service provider requirements for independent software testing services
• Definition of the market drivers and trends and how they impact on demand for services
• Competitive landscape, including identification of the major providers, their market positioning, strengths and weaknesses, and the fit of their offers to customer requirements
• Independent telecom software testing market size and forecast by region from 2011-2016, and share of the market leaders

The research involved telephone interviews and online surveys with the top testing providers as well as communications service providers on all continents, covering the fixed, mobile, media and Internet segments.

This report is an invaluable source of information for telecom testing executives worldwide seeking to establish how and where the world's independent telecom software testing market is expected to grow over the next 5 years, where the industry is heading in the coming years and what services and support customers are expecting.
Analysis of the current communications service provider requirements for independent software testing services.

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181604-software-testing-for-csps-market-analysis.html

Report Details:
Published: June 2012
No. of Pages: 60
Price: Single User License- US $2000              
                                  

Global Markets and Technologies for Carbon Nanotubes

REPORT HIGHLIGHTS

• The global market for various carbon nanotubes (CNT) grades was $192 million in 2011. In 2012, it is estimated to generate nearly $239 million in revenues, and projected to grow over the next five years at a compound annual growth rate (CAGR) of 22.4%, reaching $527 million by 2016.
• The global market for multi-walled carbon nanotubes (MWNTs) is estimated to rise from $219 million in 2012 to $292 million in 2016, a CAGR of 9.1% between 2011 and 2016.
• The global market for few-walled carbon nanotubes (FWNTs) is estimated to reach $1.8 million in 2012 and $120 million in 2016, a CAGR of 131.6% between 2011 and 2016.

REPORT SCOPE

INTRODUCTION

MOTIVATION

Among the numerous categories in the evolving field of newly synthesized nanomaterials, carbon nanotubes (CNTs) are perhaps among the most dynamic and undergoing the most rapid pace of development.  The past five years have witnessed relentless growth in the research, development and technological understanding of these remarkable materials.  Universities, small businesses and start-ups, as well as large corporations, have continued to probe and exploit numerous commercial possibilities for these fascinating materials.  As a result, the list of product applications is expanding considerably and is projected to do so well into the future.

The most tangible evidence for growth and interest is reflected by the emergence of new CNT producers now capable of offering CNTs in commercial-scale quantities—in kilograms, tonnes and even hundreds of tonnes, depending on the specific grade—at more affordable and increasingly competitive unit pricing.  In addition, after several years of incubation, there is a new breed of more mature university spin-offs, or nanotechnology companies, targeting specific application sectors.  Additional evidence of growth is the increasing presence of larger, more established corporations that recognize the future market opportunities offered by CNTs.  Finally, over the past five years, there has been phenomenal growth in patent activity.  In 2010 alone, the number of issued CNT-related U.S. patents reached 1,585, an increase of 54% over the previous year. In 2011, this increased more moderately, by 7.7%, but nonetheless reached an annual output record of 1,707.  For patents pending, the situation is even more dramatic, with a cumulative backlog from 2001 to 2011 now totaling 16,775. For the current review period (2010 to 2011 total output alone reached 54% of the previous period (2001 to 2009).

In view of the technical momentum—representing a multibillion-dollar technology investment—and the enormous business potential, this report provides a timely update on CNTs—their level of technical maturity, where they are starting to penetrate the marketplace, and when and where the broadening market unravels.

OBJECTIVES AND PURPOSE OF THIS REPORT

The primary objectives of this report are threefold:

• Assess the current state-of-the-art in CNT production and technical applications understanding.
• Identify the current players seeking to exploit their unique properties.
• Evaluate actual or impending markets in terms of the technical readiness of CNTs and the projected market revenues.

SCOPE OF REPORTThis updated report is divided into the following nine major chapters:

CHAPTER THREE—TECHNOLOGY OVERVIEW defines, outlines the history, describes the production methodology, identifies the unique properties of various forms of CNTs and emphasizes the major application challenges.

CHAPTER FOUR—PATENT ANALYSIS provides an extensive search/analysis of U.S. issued and pending patents (along with Canadian, European and WPTO databases where there is no USPTO presence), a collation of the main technical/application sectors and identifies the most active organizations—U.S. and foreign—driving CNT technology.

CHAPTER FIVE—INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS identifies current producers, progress in continuous production scale-up, market segmentation and an industry profile covering the major players.

CHAPTER SIX—MARKETS BY APPLICATION represents the body of the report assessing the latest progress and technical readiness in the major application sectors of composites, electronics, energy storage, membranes, sensors and other applications.

CHAPTER SEVEN—GLOBAL MARKET ANALYSIS estimates five-year potential revenues of all notable CNT producers.

CHAPTER EIGHT—NORTH AMERICAN MARKET ANALYSIS estimates five-year potential revenues of U.S. and Canadian CNT producers.

CHAPTER NINE—EUROPEAN MARKET ANALYSIS estimates five-year potential revenues of European CNT producers.

CHAPTER TEN—ASIAN MARKET ANALYSIS estimates five-year potential revenues of Asian CNT producers.

CHAPTER ELEVEN—MARKET PULL: PROGNOSIS FOR GLOBAL CNT APPLICATIONS identifies the most promising applications realizable based on the leading proponents, technical readiness and market interest.

CONTRIBUTION OF THE STUDY AND TARGET AUDIENCE
This report represents a major update to BCC Research’s report, Carbon Nanotubes: Technologies and Global Markets, NAN024D, published in January 2010.  The most significant revisions in this new edition include the following:

• An extensive patent analysis of the U.S. patent database.
• An in-depth assessment of the unfolding commercial markets.
• Progress in the synthesis and commercial scale-up of CNTs.
• Extensive compilation of the producers and end users dictating market development.
• A five-year projected market analysis of the emerging CNT industry.

This comprehensive technical and business assessment on the current status of the CNT industry should prove informative to nanomaterials manufacturers, investors seeking near-term commercialization opportunities, technologists confronted with nanomaterial device integration issues and companies interested in exploiting revolutionary nanomaterials for advanced composites, biomedical, electronic, energy storage, membranes/separation, sensing, security and other emerging applications.

METHODOLOGY AND SOURCES OF INFORMATION
This report is primarily derived from the enormous amount of patent and technical literature relating to CNTs disclosed in the public domain.  In addition, complementary information has also been drawn from the business community, such as company investment news, company profiles, press releases and personal telephone interviews with selected companies.

AUTHOR’S CREDENTIALS
John Oliver, the author of this report, is the founder of Innov8 Solutions, which provides advanced materials consultation services to industrial clients.  He has more than 30 years of industrial R&D experience in surface and colloid science spanning a wide range of materials technology.  Primarily, working as a senior scientist at Xerox Research Centre of Canada, he developed an invaluable understanding in advanced materials used in digital printing technologies such as xerography and ink-jet printing (IJP).  In the past 10 years through his involvements with the Alberta Research Council and several Alberta universities, his interests have evolved into the realm of nanomaterials and microsystems device integration.  He has a Ph.D. in Physical Chemistry from McGill University, and a BSc degree in Chemistry from Surrey University, U.K.  His publications include more than 40 technical peer-reviewed technical articles and 20 patents. Between 2005 and 2009, he was the editor of BCC’s monthly Nanoparticle News and has authored five previous BCC Research’s nanomaterial technical reports, Quantum Dots: Technical Status and Market Prospects (GB-278, NAN027B/NAN027C) and Carbon Nanotubes: Technologies and Commercial Prospects (NAN024C, NAN024D).

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181591-global-markets-and-technologies-for-carbon-nanotubes.html


Report Details:
Published: July 2012
No. of Pages: 398

Price: Single User License- US $4850                Corporate User License- US $ 8500
                                  

ReportsnReports: Home Care in Guatemala

Overview

Discover the latest market trends and uncover sources of future market growth for the Home Care industry in Guatemala with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Home Care industry in Guatemala, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Guatemala for free:

• Air Care
• Bleach
• Dishwashing
• Insecticides
• Laundry care
• Polishes
• Surface care
• Toilet care

The Home Care in Guatemala market research report includes:

• Analysis of key supply-side and demand trends
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

• What is the market size of Home Care in Guatemala?
• What are the major brands in Guatemala?
• What is the importance of the trend towards environmentally friendly products in home care?
• What are the main growth drivers of the home care market in Guatemala?

Why buy this report?

• Gain competitive intelligence about market leaders
• Track key industry trends, opportunities and threats
• Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Home Care market research database.

Sample Analysis

EXECUTIVE SUMMARY

Strong volume and value growth rates for home care
In 2011, home care in Guatemala registered healthy growth rates, both in volume and current value terms. In most categories, there is a wide range of brands with economy, standard and premium positioning, which allow consumers to purchase the products that best suit their needs. Increased urbanisation, due to the growth of Guatemala’s cities and disposable incomes, are allowing an expansion of home care’s consumer base.

New product launches bring dynamism to home care landscape
During 2011, there were several new product launches which brought dynamism to the home care landscape. Most new product launches focused on improving products with the use of new technology or ingredients. Such is the case for laundry detergent Mas Color Efecto Renovador from Henkel La Luz which was improved and now cleans and protects coloured fabrics. Similarly, Glade Refresh Air from SC Johnson de Centroamerica SA is a spray/aerosol air freshener that eliminates odours rather than simply masking them.

International brands lead home care
Home care in Guatemala was dominated by international brands from multinational companies like Unilever de Centroamérica, Procter & Gamble Interamericas Guatemala Ltd, SC Johnson de Centroamerica, and Colgate-Palmolive Centroamerica SA at the end of the review period. Most brands from these companies have a long presence in home care with strong distribution chains, and are constantly investing in new product development, marketing campaigns and promotions to increase or maintain their share. Another benefit of these companies is that they have products to cater to all economic segments of the country, with the participation of economy, standard and premium brands.

Independent small grocers remains strong in Guatemala
The majority of home care continued to be distributed through independent small grocers in Guatemala, which can reach even the most remote areas of the country. Through this channel, small pack sizes are preferred, since consumers shop on a daily or weekly basis. There is a trend of growing supermarkets in the country. The two strongest chains demonstrated this growth, with Wal-Mart Centroamérica SA reaching195 retail shops through its brands Wal-Mart (hypermarkets), Paiz (supermarkets), Despensa Familiar (discounters), Maxi Despensa (discounters) and ClubCo (warehouse clubs) in 2011; and Unisuper SA reaching 38 supermarkets. Stores are mostly located in urban centres, but they are expanding to the provinces. However, habits are harder to change, and it will take a big effort for supermarkets to change the provinces’ habits of shopping for groceries in small grocery retailers.

Large growth potential for the forecast period
Home care has a positive outlook for the future, in terms of volume and value growth. Categories such as laundry care and dishwashing are very dynamic and are continuously introducing new product launches with specific benefits that appeal to middle and upper-income consumers, usually living in urban centres. When it comes to habits in the provinces, people still use substitute products, like powder detergents to clean dishes, but these habits are beginning to change as more affordable and smaller unit pack sizes are introduced.

  
Buy your copy of this reports @ http://www.reportsnreports.com/reports/181587-home-care-in-guatemala.html


Report Details:

Published: July 2012

Price: Single User License: US$2400

Table of Contents

Home Care in Guatemala - Industry Overview

EXECUTIVE SUMMARY

Strong volume and value growth rates for home care
New product launches bring dynamism to home care landscape
International brands lead home care
Independent small grocers remains strong in Guatemala
Large growth potential for the forecast period

MARKET INDICATORS

Table 1 Households 2006-2011

MARKET DATA

Table 2 Sales of Home Care Household Care by Category: Value 2006-2011
Table 3 Sales of Home Care Household Care by Category: % Value Growth 2006-2011
Table 4 Home Care Company Shares 2007-2011
Table 5 Home Care Brand Shares 2008-2011
Table 6 Penetration of Private Label by Category 2006-2011
Table 7 Sales of Home Care by Distribution Format: % Analysis 2006-2011
Table 8 Sales of Home Care by Category and Distribution Format: % Analysis 2011
Table 9 Forecast Sales of Home Care by Category: Value 2011-2016
Table 10 Forecast Sales of Home Care by Category: % Value Growth 2011-2016

DEFINITIONS

SOURCES

Summary 1 Research Sources

Home Care in Guatemala - Company Profiles

Industria La Popular SA in Home Care (Guatemala)
STRATEGIC DIRECTION
KEY FACTS
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Industria La Popular SA: Competitive Position 2011

Air Care in Guatemala - Category Analysis

HEADLINES

TRENDS

In 2011, air care witnessed value growth of 10% in current terms, and sales of GTQ52 million. Standard spray/aerosol air fresheners is the most used product, due to its longstanding presence and more affordable unit price. In 2011, its current value sales represented 86% share of the category’s value sales.

COMPETITIVE LANDSCAPE

Air care was led mainly by two companies in Guatemala in 2011: SC Johnson de Centroamerica SA held a current value share of 54% with its leading brand Glade, and Reckitt Benckiser with its brand Air Wick accounted for 36% value share.

PROSPECTS

Air care is expected to continue to grow over the forecast period, with a CAGR of 6% in constant value terms, to reach sales of GTQ70 million in 2016. This category has great potential growth due to the dynamism that new product launches bring.

CATEGORY DATA
Table 11 Sales of Air Care by Category: Value 2006-2011
Table 12 Sales of Air Care by Category: % Value Growth 2006-2011
Table 13 Air Care Company Shares 2007-2011
Table 14 Air Care Brand Shares 2008-2011
Table 15 Forecast Sales of Air Care by Category: Value 2011-2016
Table 16 Forecast Sales of Air Care by Category: % Value Growth 2011-2016


Contact sales@reportsandreports.com to order your copy of this report

Home Improvement: Category Overview

Home Improvement: Category Overview global briefing offers the big picture view of the size and shape of the Home and Garden market. The report delivers strategic insight into some of the key areas of the market, including emerging regions, countries and categories, as well as pressing industry issues and white spaces. It identifies opportunities, analyses leading companies and brands, and offers analysis of major factors influencing the market. Forecasts illustrate how the market is set to change and criteria for success

The global economic downturn has hit the global home improvement market hard, with the North American market particularly weak. Many consumers have less money to spend, and with housing values declining in many places, they can no longer justify expenditure on home improvement as an investment that will add to the value of their home. On the other hand, a combination of urbanisation and income growth is driving strong growth in emerging markets, most notably in China.

Product coverage: Gardening, Home Furnishings, Home Improvement, Homewares.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Home and Garden market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Published: July 2012
No. of Pages: 57
Price : US$2000

Euromonitor International has over 40 years'' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table of Contents :

• Introduction
• Socio-economic Drivers
• Category Analysis
• Regional Analysis
• Channel Analysis
• Forecast
• Report Definitions

 Buy your copy of this report @ http://www.reportsnreports.com/reports/180515-home-improvement-category-overview.html. Contact sales@reportsandreports.com for further information.

Complete 2012 Induced Pluripotent Stem Cell Industry Report

Pre-Order Now for a 5% Discount - Upcoming research on Induced Pluripotent Stem Cell Industry


Format: PDF
Available from August 15th, 2012
Price : Single User License: US$3495             Corporate User License: US$5495

Executive Summary
Stem cell research and experimentation has been in process for well over five decades. Stem cells have the unique characteristics whereby they are able to divide and replicate repeatedly in addition to their being “unspecialized” with the ability to differentiate into specialized cell types. The possibilities that arise with the perfecting of cell replication has caused this area of exploration to remain on the forefront of scientific research, with ongoing hope that cures and treatment of diseases as well as reparative cell therapy, tissue regeneration and pharmacological testing on cell-specific tissue will one day become viable options within the medical community. Diseases such as Huntington’s Chorea, Parkinson’s Disease, and spinal cord injuries are just some examples of potential clinical applications where stem cells can offer potential benefits in halting or even reversing medical conditions that previously had no positive outcome potential – and induced pluripotent stem cells represent a preferred cell type for this type of disease reversal research.

Traditionally, scientists have worked with both embryonic and adult stem cells. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding the use of embryonic cells for research. Although adult stem cells can differentiate slightly, they are typically limited to differentiation within their original tissue type, creating narrow options for their use.

Discovery:
Groundbreaking experimentation in 2006 led to the introduction of “induced pluripotent stem cells” (iPSC). These are adult cells which are isolated and then transformed into embryotic-like stem cells through the manipulation of gene expression as well as other methods. Research and experimentation using mouse cells at Kyoto University in Japan was the first instance where there was successful generation of the iPSC. In 2007, a series of follow-up experiments were done at Kyoto University in Japan where human adult cells were transformed into iPSC cells.

While there is excitement at the prospect of what such artificially remanufactured cells can contribute to medical advances, there have been issues along the way which have proven to be prohibitive. By 2010, there were a number of private industries ready to capitalize on this breakthrough technology. One such company, Advanced Cell Technology in Worcester, Massachusetts, discovered some problematic issues as they conducted experiments prior to applying for U.S. Food and Drug Administration approval to utilize iPSC in therapeutic capacities. Concerns such as premature cell death, mutation into cancer cells and low proliferation rates were some of the problems that surfaced.

Contact sales@reportsandreports.com to order your copy of this report

Research Advances:
Continued research and experimentation has resulted in numerous advances and triumphs over the last few years. According to “Circulation Research” (2012), the University of Michigan developed innovative methods to use bioengineered stem cells derived from skin biopsies to create cardiac muscle cells. This accomplishment has allowed advanced research to take place in treating medical therapies and drug treatments in diseased heart muscle.

Advances will continue to be perfected in the areas of reprogramming adult cells in appropriate conditions that will result in minimal negative outcomes. Original techniques, such as viral induced transcription processes, are being replaced with newer technology as private industries join with the scientific community to develop safe and efficient methods. With sustained research and experimentation, established guidelines related to safety and efficacy can be developed. Induced pluripotent stem cells are a promising therapy for many previously incurable medical diseases.

Market Metrics – iPSC Research Products:
For this reason a large and thriving research products market has grown into existence for this cell type. Induced pluripotent stem cells (iPSC) are now sold by 53.4% of U.S. research product companies, and 38.7% of research product companies worldwide. Annual growth in the number of iPSC research product sold worldwide has been growing at a rate of 14.7% per year for the past five years. In addition, 31% of all stem cell researchers identify as having using iPSC for a research project. It is clear that iPSC are a vital research trend within the scientific community. Therapeutic applications of iPSC are considered, but within the context of the research product opportunities these trends represent.

Perhaps the most distinctive feature of this report are the breakthrough findings discovered as a result of surveying 293 researchers that identify as having induced pluripotent stem cells as their core research focus. Of the 293 respondents, 181 were U.S. based and 112 were international. These key survey findings reveal iPSC researcher wants and needs, technical preferences, and key factors influencing buying decisions. These vital findings can be used to direct the product development and product positioning decisions. Remember, to benefit from this lucrative product market, you need to anticipate and serve the needs of your clients, or your competitors will.

Key Findings Include:

• Charts, Timelines, Metrics and Financials for the iPSC Research Product Market
• Trends for iPSC Grants, Publications, Patents, and More
• 5-Year Market Projection Data for 2012-2017
• Competitive Environment Analysis, Including Market Share by Competitor
• Preferred Species for iPSC Research
• iPSC Product Categories (Breakdown of Market Share by Each)
• Consumer Behavioral Patterns and Preferred Providers
• Crucial Trends and Unmet Market Needs
• “Tested Sentences” for Selling to iPSC Scientists
• Trends in Marketing, Including a Breakdown of the Marketing Methods Used by Your Competition – Google Ads, Facebook Ads, App Advertising, Purchased Email Lists, Website Advertisements, Trade Journals, and More.
• End-User Wants/Needs, Technical Preferences, and Factors Influencing Purchasing Decisions (Survey of iPSC Researchers)

In summary, this is a must-read industry report for research supply companies to optimally position themselves to sell iPSC research products. To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the market place, and take advantage crucial iPSC trends. Claim this report now to profit from this expanding market- or your competition will.

• Format: PDF
• No. of Pages : 157
• Available from : August 15th, 2012
• Pre-Order Now for a 5% Discount
• Price : Single User License: US$3495             Corporate User License: US$5495

Contact sales@reportsandreports.com to order your copy of this report.